EUVIMEDEUVIMED entdecken
Crossref

Research Progress on Hyperlipidemia

成消 李

Advances in Clinical Medicine · 2024 · 14 (01) · 1635-1646

DOI: 10.12677/acm.2024.141235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Clinical Medicine, 2024. Verfasst von 成消 李. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This article provides a comprehensive review on the classification of hyperlipidemia, research progress in drug therapy, and the importance of diet and exercise management. Firstly, hyperlipidemia can be classified into primary and secondary types based on different etiological factors and genetic backgrounds. Secondly, significant progress has been made in drug therapy, including cholesterol-lowering drugs and triglyceride-lowering drugs. Statins are the cornerstone of cholesterol-lowering treatment, while other drugs such as cholesterol absorption inhibitors and PCSK9

Zitieren

APA

李, 成. (2024). Research Progress on Hyperlipidemia. Advances in Clinical Medicine, 14(01), 1635-1646. https://doi.org/10.12677/acm.2024.141235

Vancouver

李 成. Research Progress on Hyperlipidemia. Advances in Clinical Medicine. 2024;14(01):1635-1646. doi:10.12677/acm.2024.141235

BibTeX
@article{2024,
  author = {李, 成消},
  title = {Research Progress on Hyperlipidemia},
  journal = {Advances in Clinical Medicine},
  year = {2024},
  volume = {14},
  number = {01},
  pages = {1635--1646},
  doi = {10.12677/acm.2024.141235}
}
Kostenlos starten →